Caas Capital Management »

Vertex Pharmaceuticals Incorporated shares owned by Caas Capital Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Caas Capital Management from 13F filings

Historical chart of Caas Capital Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Caas Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Caas Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $630k 1.3k 484.82
2021-03-31 $26M 119k 214.88
2020-03-31 $594k 2.5k 237.78

More positions owned by Caas Capital Management

Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Apple (AAPL)
Citigroup Com New (C)
Goldman Sachs (GS)
JPMorgan Chase & Co. (JPM)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Wells Fargo & Company (WFC)
Bank of America Corporation (BAC)
Morgan Stanley Com New (MS)
Asml Holding N V N Y Registry Shs (ASML)
International Business Machines (IBM)
Visa Com Cl A (V)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Caas Capital Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated